Poststroke depression

Also known as: Post-stroke Depression / Post stroke depression

Drug	Drug Name	Drug Description
DB00370	Mirtazapine	A tetracyclic antidepressant used in the treatment of major depression and is used off-label as a drug for insomnia and to increase appetite.

Drug	Drug Name	Target	Type
DB00370	Mirtazapine	5-hydroxytryptamine receptor 2A	target
DB00370	Mirtazapine	5HT3 serotonin receptor	target
DB00370	Mirtazapine	Alpha-2A adrenergic receptor	target
DB00370	Mirtazapine	5-hydroxytryptamine receptor 2C	target
DB00370	Mirtazapine	Kappa-type opioid receptor	target
DB00370	Mirtazapine	Histamine H1 receptor	target
DB00370	Mirtazapine	Cytochrome P450 1A2	enzyme
DB00370	Mirtazapine	Cytochrome P450 3A4	enzyme
DB00370	Mirtazapine	Cytochrome P450 2D6	enzyme
DB00370	Mirtazapine	Alpha-1 adrenergic receptors	target
DB00370	Mirtazapine	Sodium-dependent serotonin transporter	transporter

Drug	Drug Name	Phase	Status	Count
DB01221	Ketamine	1	Recruiting	1
DB04835	Maraviroc	2	Completed	1
DB00472	Fluoxetine	Not Available	Completed	1